Friesland Bk Eurorente Fds NV (OPERF) Share Price

If neither MAA approval comes nor 3-71 results are extremely good, then...there is no NPV calc that makes sense because the stock would be sitting at ~$350m based purely on speculation that the company could run a pair of truly effective PD P3 trials.

So, according to your AVXL analys

its actually significant to me, thanks for sharing

Interesting, and the foot dragging MHRA isn't helping the field to stand on its feet.

VMIR (As Of 3/20/25)

Daily Performance
Value Microcap Index:-0.18%
Value Microcap Index Rebalanced:-0.02%

Overall Performance
Value Microcap Index: -7.80%
Value Microcap Index Rebalanced:-7.46%

VMIR (As Of 3/20/25)

Daily Performance
Value Microcap Index:-0.18%
Value Microcap Index Rebalanced:-0.02%

Overall Performance
Value Microcap Index: -7.80%
Value Microcap Index Rebalanced:-7.46%

If anyone's looking for a quick and hassle-free way to access PUSOF, I highly recommend using https://govplus.pissedconsumer.com/review.html govplus . They streamline the whole application process and make it super easy to stay on top of your government services. Definitely worth checking out!

I'd love to! How can I profit or recoup my losses when I'm in the red. Seriously,I'd love to get rid of the eye sore!

Tech . I like your style!😎🤙

"Jacqui Heinrich", stay tuned.

Waaa I'm crying and hiding under Mommy's skirt. I'm sure that really worked well for you in 4th grade.

EDGX loading up shares at $6.61 post market.

Republican Rep. Lawler condemns closure of lone Social Security office in district

Rep. Michael Lawler (R-New York) denounced the Social Security Administration’s shift to close the lone agency hearing office in his district, calling the move “a slap in the face” to his constituents.

Haters all-

https://media.gettr.com/group5/getter/2025/03/20/21/0dd7b0b5-97d3-395b-73fb-de374d68d115/b764b23f4392f9f55bd2977ad450e17d_768x0.jpg

Your anger is misdirected. I am not the one that ripped you off. I'm not the one who has your money.

https://www.fiercebiotech.com/biotech/uk-cell-therapy-biotech-lays-25-staff-turns-tool-development-over-therapeutics

Maybe Advent can pick up some talent...

Yes, the markets should respond well if the policies get implemented and time for them to work.

Stopping the wars along with lower interest rates and cheaper energy should produce good results.

Here’s a quick lesson for both Americans and Canadians.

Here are just some historic tariffs
Canada hits America with:

Milk: 270%
Cheese: 245%
Butter: 298%
Chicken: 238%
Sausages: 69.9%
Barley seed: 57.8%
Bovine/meat: 26.5

Bioamber is involved with those sectors and as long as my shares remain intact I'm very invested and will be part of the next step transaction and therefore Bioamber is not gone and neither of you or he since you enjoy talking about people's investment in this special company

How will it end is the question? Everything that has a beginning always has an ending, like a book.

https://scontent-lax3-2.xx.fbcdn.net/v/t39.30808-6/480940268_1166126018860218_4386182022733409292_n.jpg?_nc_cat=111&ccb=1-7&_nc_sid=833d8c&_nc_ohc=5eoNMoxRIy0Q7kNvgHDnB63&_nc_oc=AdnfblkQ3YMuQ2Ad2ofxOQ_l30c6zGGLrPjVkQoUbuYCF_8cQQEYztbCCdUUGCY_j6A&_nc_zt=23&_nc_ht=scontent-lax3-2.xx&_nc_gid=BmKumQQVA1

Has anyone substantiated the comment related to required CET1 levels only being satisfied via retained earnings? The comment was supposedly made during the Urban Institute roundtable. Was it just related to while in conservatorship they are excluded from doing so?

Current Required

You made the claim. Provide it.

Yep in total agreement with trial size being a problem in the past and possibly with the 2-71 trial. There were other problems as well cro vetting , disclosure of data, missed timelines . My personal opinion is his only brilliant move these last 3 years was hiring Dr. Jung ,,, try to imagine where w

IDK...if MAA is approved then let's say $3b in Revenue in 2028 and work back 3 years - say $15b MC discounted back 20% each year...so roughly $7.5b-$8b market cap? If MAA is not approved but 3-71 results are good then purely based on schizophrenia and approval coming n 2028 and $1b in sales in 2031

.10+ is my target. Might be a bit choppy on the way but ideally we get a parabolic run past that level. If we hit .25 or .50+ all bets are off. We know these things can go parabolic in a hurry, and with the share structure of ZHUD, anything remains possible.